China Holdings, Inc. to Present at 3rd China Healthcare Industry Business Opportunity Trade Conference

LAS VEGAS, May 10 /Xinhua-PRNewswire-FirstCall/ -- China Holdings, Inc. (OTC Bulletin Board: CHHH), a global holding company and its subsidiaries engage in multiple China-focused business activities including pharmaceutical, real estate, utilities, energy and finance, today announced that the Company's Chief Executive Officer and Founder JULIANNA LU will present at the China Healthcare Industry Business Opportunity Trade Conference held in Beijing China on May 19th, 2007.

During the presentation, China Holdings, Inc., JULIANNA LU, the Company's Chief Executive Officer will provide an overview of the China-based pending pharmaceutical acquisitions and strategy to integrate China-SFDA drug producers and drug pipelines, distribution channels, and management expertise in China and worldwide.

The 3rd China Healthcare Industry Business Opportunity Trade Conference is Sponsored by China Nonprescription Medicines Association, China Academic Society of Native Medicine, Chamber of Commerce of Medicine Industry of All-China Federation of Industry & Commerce, National Association of Health Industry and Enterprise Management, Organizing Committee of the Development Forum for Growth Pharmaceutical Enterprises of China, Sales and Marketing, Contemporary Medicine Market, China Business; Organized by Beijing Chuang Yi Xing Tong Media Group, Lonxitan; with Media Supporting by China Pharmaceutical News, Medicine Economic News, Health News, China News Of Traditional Chinese Medicine, 21st Century Drugstores, China Women's News, sina.com, sohu.com, baidu.com, tom.com, and 163.com.

About China Holdings, Inc.

China Holdings, Inc. is a global holding company with two wholly-owned subsidiaries: (i) China Health Holdings, Inc. and (ii) China Health World Trade Corporation. The Company's objective is to achieve long-term capital appreciation by investing in companies and other entities with significant assets, revenues, investments, production activities, trading and business interests in China.

About China Health Holdings, Inc.

China Health Holdings, Inc. a wholly owned subsidiary of China Holdings, Inc., is a development stage company with the goal of becoming a leading developer, manufacturer, marketer and distributor of pharmaceutical drugs and dietary supplements in China and worldwide. The Company's main objective is to partner with SFDA approved drug producers, GMP certified manufacturing facilities, research and development centers and universities in China. The Company's immediate goals for 2007 include the profitable penetration of the Chinese pharmaceutical industry by acquiring leading pharmaceutical companies in the China. The Company's strategy is to leverage synergies, integrate drug pipelines and distribution channels, and management expertise between pending acquisitions.

Please visit http://www.chinahealthholding.com for more information on the Company.

For worldwide investor and media inquiries, please contact:

China Holdings, Inc., Las Vegas

Mr. Xiaofei Yu

President, Corporate Development

Tel: +1-604-608-6788; +1-877-883-0979 (North America)

Tel: +86-1370-133-1287 (China)

Email: info@chinahealthholding.com

Ogilvy Public Relations Worldwide

Mr. Rory Macpherson

Consultant

Tel: +86-10-8520-6553

Email: rory.macpherson@ogilvy.com

Safe Harbor Statement: To the extent that statements in the press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company's development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward looking, all forward-looking statements, whether written or oral, and whether made by or on behalf of the Company, are expressly qualified by the cautionary statements and any other cautionary statements, which may accompany the forward-looking statements, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Other important factors that could cause actual results to differ materially include the following: business conditions and the amount of growth in the Company's industry and general economy; competitive factors; ability to attract and retain personnel; the price of the Company's stock; and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. In addition, the company disclaims any obligation to update or correct any forward-looking statements in all of the Company's press releases to reflect events or circumstances after the date hereof.